Asarfi Hospital Ltd vs Thyrocare Technologies Ltd Stock Comparison
Asarfi Hospital Ltd vs Thyrocare Technologies Ltd Stock Comparison
Last Updated on: Oct 24, 2026
Key Highlights
The Latest Trading Price of Asarfi Hospital Ltd is ₹ 229.9 as of 17 Jun 10:31
. The P/E Ratio of Asarfi Hospital Ltd changed from 31 on March 2024 to 20 on March 2026 . This represents a CAGR of -13.59% over 3 yearsThe P/E Ratio of Thyrocare Technologies Ltd changed from 42.2 on March 2021 to 34.2 on March 2026 . This represents a CAGR of -3.44% over 6 years The Market Cap of Asarfi Hospital Ltd changed from ₹ 128.55 crore on March 2024 to ₹ 333.63 crore on March 2026 . This represents a CAGR of 37.42% over 3 yearsThe Market Cap of Thyrocare Technologies Ltd changed from ₹ 4774 crore on March 2021 to ₹ 5566 crore on March 2026 . This represents a CAGR of 2.59% over 6 years The revenue of Asarfi Hospital Ltd for the Jun '26 is ₹ 48.1 crore as compare to the Mar '26 revenue of ₹ 45.89 crore. This represent the growth of 4.82% The revenue of Thyrocare Technologies Ltd for the Jun '26 is ₹ 244.88 crore as compare to the Mar '26 revenue of ₹ 228.84 crore. This represent the growth of 7.01% The ebitda of Asarfi Hospital Ltd for the Jun '26 is ₹ 10.02 crore as compare to the Mar '26 ebitda of ₹ 8.36 crore. This represent the growth of 19.86% The ebitda of Thyrocare Technologies Ltd for the Jun '26 is ₹ 82.13 crore as compare to the Mar '26 ebitda of ₹ 79.98 crore. This represent the growth of 2.69% The net profit of Asarfi Hospital Ltd changed from ₹ 1.45 crore to ₹ 4.27 crore over 9 quarters. This represents a CAGR of 61.61%
The net profit of Thyrocare Technologies Ltd changed from ₹ 23.94 crore to ₹ 51.33 crore over 9 quarters. This represents a CAGR of 40.35%
The Dividend Payout of Asarfi Hospital Ltd changed from 0 % on March 2021 to 0 % on March 2026 . This represents a CAGR of 0.0% over 6 yearsThe Dividend Payout of Thyrocare Technologies Ltd changed from 110.36 % on March 2021 to 149.75 % on March 2026 . This represents a CAGR of 5.22% over 6 years .
About Asarfi Hospital Ltd
Asarfi Hospital Limited was originally incorporated as Private Limited Company in the name of 'Asarfi Hospital Private Limited' on October 4, 2005 issued by Registrar of Companies, Bihar & Jharkhand.
Subsequently, status of the Company was converted into Public Limited and name of the Company was changed to 'Asarfi Hospital Limited' vide a fresh Certificate of Incorporation dated February 08, 2012 issued by Registrar of Companies, Jharkhand.
Asarfi Ltd is a 250 bedded Multi Speciality Hospital, which is serving people for more than one and half decade by providing healthcare services in Dhanbad, Jharkhand.
Accredited by National Accreditation Board for Testing and Calibration Laboratories (NABL Accredited).
The Company is an integrated healthcare service provider, committed to deliver quality healthcare services to their patients in modern facilities that includes prevention, best treatment and proper rehabilitation.
About Thyrocare Technologies Ltd
Thyrocare Technologies Limited was incorporated in January, 2000.
The Company operates in the healthcare industry and is involved in providing quality diagnostic services at affordable costs to patients, laboratories and hospitals in India.
As of 31 March 2025, the Company offered more than 920 distinct tests that support early detection, preventive care and the ongoing disease monitoring.
Their 43 profiles are administered under its reputed 'Aarogyam' brand, which offers patients a suite of wellness and preventive health care tests.
The Company primarily operates its testing services through a fully automated Centralised Processing Laboratory (the CPL) and has expanded its operations to include a network of Regional Processing Laboratories (RPLs).
The company currently operates 25 RPLs, one in each of New Delhi, Coimbatore, Hyderabad, Kolkata, Bangalore, Bhopal, Mumbai Patna and Chennai, which process samples sourced from their respective regions.
FAQs for the comparison of Asarfi Hospital Ltd and Thyrocare Technologies Ltd
Which company has a larger market capitalization, Asarfi Hospital Ltd or Thyrocare Technologies Ltd?
Market cap of Asarfi Hospital Ltd is 334 Cr while Market cap of Thyrocare Technologies Ltd is 7,357 Cr
What are the key factors driving the stock performance of Asarfi Hospital Ltd and Thyrocare Technologies Ltd?
The stock performance of Asarfi Hospital Ltd and Thyrocare Technologies Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.
What are the recent stock price for Asarfi Hospital Ltd and Thyrocare Technologies Ltd?
As of October 24, 2026, the Asarfi Hospital Ltd stock price is INR ₹170.1. On the other hand, Thyrocare Technologies Ltd stock price is INR ₹462.25.
How do dividend payouts of Asarfi Hospital Ltd and Thyrocare Technologies Ltd compare?
To compare the dividend payouts of Asarfi Hospital Ltd and Thyrocare Technologies Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.